References
- Varicella and herpes zoster vaccines: WHO position paper, June. 2014. Releve Epidemiologique Hebdomadaire. 2014 Jun 20;89(25):265–287.
- Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 5th ed. Philadelphia, PA: Saunders Elsevier; 2008.
- Seward J, Jumaan A VSV: Persistence in the population. In: Arvin A, Campadelli-Fiume G, Mocarski E, et al. editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007. Chapter 40. Available from: https://www.ncbi.nlm.nih.gov/books/NBK47367/
- Yawn BP, Gilden D. The global epidemiology of herpes zoster. Neurology. 2013 Sep 3;81(10):928–930.
- Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: Towards a global perspective. BMJ Open. 2014 Jun 10;4(6):e004833.
- Riera-Montes M, Bollaerts K, Heininger U, et al. Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization. BMC Infect Dis. 2017 May 18;17(1):353.
- Wolfson LJ, Castillo ME, Giglio N, et al. Varicella healthcare resource utilization in middle income countries: A pooled analysis of the multi-country MARVEL study in Latin America & Europe. Hum Vaccin Immunother. 2019 Jan 25;15(4):932–941.
- Banz K, Wagenpfeil S, Neiss A, et al. The burden of varicella in Germany. Potential risks and economic impact. Eur J Health Econ. 2004 Feb;5(1):46–53.
- Gater A, Uhart M, McCool R, et al. The humanistic, economic and societal burden of herpes zoster in Europe: A critical review. BMC Public Health. 2015 Feb 15:193.
- Friesen KJ, Chateau D, Falk J, et al. Cost of shingles: Population based burden of disease analysis of herpes zoster and postherpetic neuralgia. BMC Infect Dis. 2017 Jan 13;17(1):69.
- Panatto D, Bragazzi NL, Rizzitelli E, et al. Evaluation of the economic burden of Herpes Zoster (HZ) infection. Hum Vaccin Immunother. 2015;11(1):245–262.
- Clements DA. Varicella vaccination in children. Biodrugs. 2000 Jul;14(1):49–60.
- Takahashi M. Current status and prospects of live varicella vaccine. Vaccine. 1992;10(14):1007–1014.
- European Centre for Disease Prevention and Control (ECDC). [cited 2019 Feb 4]. Available at: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/Varicella-Guidance-2015.pdf
- Kreth HW, Lee BW, Kosuwon P, et al. Sixteen years of global experience with the first refrigerator-stable varicella vaccine (Varilrix). Biodrugs. 2008;22(6):387–402.
- Varivax. Prescribing Information. [Cited 2019 Feb 13]. Available at: https://www.merck.com/product/usa/pi_circulars/v/varivax/varivax_pi.pdf
- Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention. MMWR Recomm Rep. 1996 Jul 12;45(RR–11):1–36.
- Ferrera G, Gajdos V, Thomas S, et al. Safety of a refrigerator-stable varicella vaccine (VARIVAX) in healthy 12- to 15-month-old children: A randomized, double-blind, cross-over study. Hum Vaccines. 2009 Jul;5(7):455–460.
- Varivax. Summary of product characteristics. [cited 2019 Feb 13]. Available at: https://www.hpra.ie/docs/default-source/vaccine-pils/varivax.pdf?sfvrsn=22
- Priorix-Tetra. Summary of product characteristics. [cited 2019 Apr 10]. Available at: https://gskpro.com/content/dam/global/hcpportal/en_MT/PDF/Homepage/Products/productlisting/priorix-tetra/Priorix_Tetra_PI_II_078_18_Apr_2017.pdf
- ProQuad. Summary of product characteristics. [cited 2019 Apr 10]. Available at: https://www.ema.europa.eu/en/documents/product-information/proquad-epar-product-information_en.pdf
- ProQuad. EPAR. [cited 2019 Feb 13]. Available at: https://www.ema.europa.eu/en/medicines/human/EPAR/proquad#authorisation-details-section
- Lopez AS, Zhang J, Brown C, et al. Varicella-related hospitalizations in the United States, 2000–2006: The 1-dose varicella vaccination era. Pediatrics. 2011 Feb;127(2):238–245.
- Marin M, Meer HC, Seward JF. Varicella prevention in the United States: A review of successes and challenges. Pediatrics. 2008 Sep;122(3):e744–51.
- Lee BR, Feaver SL, Miller CA, et al. An elementary school outbreak of varicella attributed to vaccine failure: Policy implications. J Infect Dis. 2004 Aug 1;190(3):477–483.
- Povey M, Henry O, Riise Bergsaker MA, et al. Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trial. Lancet Infect Dis. 2019 Mar;19(3):287–297.
- Varicella vaccines. WHO position paper. Releve Epidemiologique Hebdomadaire. 1998 Aug 7;73(32):241–248.
- Spoulou V, Alain S, Gabutti G, et al. Implementing universal varicella vaccination in Europe: The path forward. Pediatr Infect Dis J. 2019 Feb;38(2):181–188.
- Amodio E, Tramuto F, Cracchiolo M, et al. The impact of ten years of infant universal varicella vaccination in Sicily, Italy (2003–2012). Hum Vaccin Immunother. 2015;11(1):236–239.
- Empfehlungen der Ständigen Impfkommission am Robert-Koch-Institut (STIKO). Epidemiol Bull 2004; 49: 421–432. [cited 2019 Feb 4]. Available at: https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2004/Ausgabenlinks/49_04.pdf%3F__blob%3DpublicationFile
- Siedler A, Arndt U. Impact of the routine varicella vaccination programme on varicella epidemiology in Germany. Euro Surveill. 2010 Apr 1;15(13):19530.
- Methley AM, Campbell S, Chew-Graham C, et al. PICO, PICOS and SPIDER: A comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews. BMC Health Serv Res. 2014 Nov;21(14):579.
- Centre for Reviews and Dissemination. Systematic Reviews. CRD’s guidance for undertaking reviews in health care. 2009 [cited 2019 Aug 19]. Available at: https://www.york.ac.uk/media/crd/Systematic_Reviews.pdf
- Harder T, Takla A, Eckmanns T, et al. PRECEPT: An evidence assessment framework for infectious disease epidemiology, prevention and control. Euro Surveill. 2017 Oct;22(40). doi:10.2807/1560-7917.ES.2017.22.40.16-00620.
- The Cochrane Collaboration: The Cochrane Collaboration’s tool for assessing risk of bias. Cochrane handbook for systematic reviews of interventions. 2011 [cited 2019 Nov 1]. Available at: http://handbook-5-1.cochrane.org/.
- Bollaerts K, Riera-Montes M, Heininger U, et al. A systematic review of varicella seroprevalence in European countries before universal childhood immunization: Deriving incidence from seroprevalence data. Epidemiol Infect. 2017 Oct;145(13):2666–2677.
- Horn J, Damm O, Greiner W, et al. Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study. BMC Med. 2018 Jan 9;16(1):3.
- Nardone A, de Ory F, Carton M, et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine. 2007 Nov 7;25(45):7866–7872.
- Siedler A, Dettmann M. Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany. Hum Vaccin Immunother. 2014;10(12):3594–3600.
- Siedler A, Dettmann M, Tolksdorf K, et al. Laboratory investigations of vaccinated patients with varicella. Vaccine. 2015 Apr 15;33(16):1968–1973.
- Siedler A, Hecht J, Rieck T, et al. Varicella vaccination in Germany. A provisional appraisal in the context of MMR vaccination. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Sep;56(9):1313–1320. German
- Streng A, Grote V, Rack-Hoch A, et al. Decline of neurologic varicella complications in children during the first seven years after introduction of universal varicella vaccination in Germany, 2005–2011. Pediatr Infect Dis J. 2017 Jan;36(1):79–86.
- Zoch-Lesniak B, Tolksdorf K, Siedler A. Trends in herpes zoster epidemiology in Germany based on primary care sentinel surveillance data, 2005–2016. Hum Vaccin Immunother. 2018 Jul 3;14(7):1807–1814.
- Spackova M, Wiese-Posselt M, Dehnert M, et al. Comparative varicella vaccine effectiveness during outbreaks in day-care centres. Vaccine. 2010 Jan 8;28(3):686–691.
- Gvozdenovic E, Vetter V, Willame C, et al. Impact of history of febrile convulsions on the risk difference of febrile convulsions with the tetravalent measles-mumps-rubella-varicella vaccine: Post-hoc exploratory analysis of results from a matched-cohort study. Vaccine. 2018 Sep 18;36(39):5803–5806.
- Hagemann C, Seeger K, Kramer A, et al. [Varicella vaccination coverage and possible factors influencing parental vaccination decisions in Munich area 2009–2011 after introduction of routine varicella vaccination]. Gesundheitswesen. 2017 Apr;79(4):286–295. German
- Hagemann C, Streng A, Kraemer A, et al. Heterogeneity in coverage for measles and varicella vaccination in toddlers - analysis of factors influencing parental acceptance. BMC Public Health. 2017 Sep 19;17(1):724.
- Hecht J, Siedler A. The epidemiology of varicella disease in Germany after introduction of a vaccination recommendation: Analysis of mandatory and sentinel data between 2002 and 2014. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Jan;60(1):118–126. German
- Horn J, Karch A, Damm O, et al. Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination. Hum Vaccin Immunother. 2016 Jul 2;12(7):1766–1776.
- Rieck T, Feig M, Ander Heiden M, et al. Assessing varicella vaccine effectiveness and its influencing factors using health insurance claims data, Germany, 2006 to 2015. Euro Surveill. 2017 Apr 27;22(17). DOI:10.2807/1560-7917.ES.2017.22.17.30521.
- Siedler A, Rieck T, Tolksdorf K. Strong additional effect of a second varicella vaccine dose in children in Germany, 2009–2014. J Pediatr. 2016 Jun;173:202–206e2.
- Streng A, Wiegering V, Liese JG. Varicella in pediatric oncology patients in the post-vaccine era-Analysis of routine hospital data from Bavaria (Germany), 2005–2011. Pediatr Hematol Oncol. 2016 Oct - Nov;33(7–8):468–479.
- Wiese-Posselt M, Siedler A, Mankertz A, et al. Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany. BMC Infect Dis. 2017 May 19;17(1):356.
- Bauchau V, Van Holle L, Cohen C. Modelling hospitalisation ratios for febrile convulsions and severe varicella under combined measles, mumps, rubella, and varicella (MMRV-Priorix-TetraTM) compared to separate MMR + V vaccination. Drug Saf. 2015 Nov;38(11):1095–1102.
- Grote V, von Kries R, Springer W, et al. Varicella-related deaths in children and adolescents–Germany 2003–2004. Acta Paediatr. 2008 Feb;97(2):187–192.
- Hohle M, Siedler A, Bader HM, et al. Assessment of varicella vaccine effectiveness in Germany: A time-series approach. Epidemiol Infect. 2011 Nov;139(11):1710–1719.
- Liese JG, Cohen C, Rack A, et al. The effectiveness of varicella vaccination in children in Germany: A case-control study. Pediatr Infect Dis J. 2013 Sep;32(9):998–1004.
- Liese JG, Grote V, Rosenfeld E, et al. The burden of varicella complications before the introduction of routine varicella vaccination in Germany. Pediatr Infect Dis J. 2008 Feb;27(2):119–124.
- Neuhauser H, Poethko-Muller C. KIGGS Study Group. [Chronic and vaccine-preventable diseases in children and adolescents in Germany: Results of the KiGGS study: First follow up (KiGGS wave 1)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Jul;57(7):779–788. German
- Rack AL, Grote V, Streng A, et al. Neurologic varicella complications before routine immunization in Germany. Pediatr Neurol. 2010 Jan;42(1):40–48.
- Reuss AM, Feig M, Kappelmayer L, et al. Varicella vaccination coverage of children under two years of age in Germany. BMC Public Health. 2010 Aug 19;10:502.
- Rieck T, Feig M, Eckmanns T, et al. Vaccination coverage among children in Germany estimated by analysis of health insurance claims data. Hum Vaccin Immunother. 2014;10(2):476–484.
- Schink T, Holstiege J, Kowalzik F, et al. Risk of febrile convulsions after MMRV vaccination in comparison to MMR or MMR+V vaccination. Vaccine. 2014 Feb 3;32(6):645–650.
- Spackova M, Muehlen M, Siedler A. Complications of varicella after implementation of routine childhood varicella vaccination in Germany. Pediatr Infect Dis J. 2010 Sep;29(9):884–886.
- Streng A, Grote V, Carr D, et al. Varicella routine vaccination and the effects on varicella epidemiology - results from the bavarian varicella surveillance project (BaVariPro), 2006–2011. BMC Infect Dis. 2013 Jul 2;13(1):303.
- Streng A, Seeger K, Grote V, et al. Varicella vaccination coverage in Bavaria (Germany) after general vaccine recommendation in 2004. Vaccine. 2010 Aug 9;28(35):5738–5745.
- Sanftenberg L, Schrörs H, Schelling J: Estimation of the vaccination coverage before and after the warning about a quadrivalent vaccine against mumps, measles, rubella and varicella. Presented at the ECCMID. 2016 [cited 2019 Nov 1]. #EP0253, Available at https://www.escmid.org/escmid_publications/escmid_elibrary/.
- Federal Statistical Office: Notifiable diseases, 2017. [cited 2019 Aug 19]. Available at: http://www.gbe-bund.de/gbe10/abrechnung.prc_abr_test_logon?p_uid=gast&p_aid=14709305&p_knoten=VR&p_sprache=E&p_suchstring=varicella
- Liese J, von Kries R, Grote V, et al.: varicella zoster virus infection hospitalisations and complications in children and adolescents: Germany, 2003–2004 – final Report. Presented at the ESPID, 2006.
- Federal Statistical Office: diagnostic data of the hospitals for Germany (1994–1999), 2000. [cited 2019 Aug 19]. Available at: http://www.gbe-bund.de/gbe10/abrechnung.prc_abr_test_logon?p_uid=gast&p_aid=14709305&p_knoten=VR&p_sprache=E&p_suchstring=varicella
- Federal Statistical Office: Deaths, Mortality figures (from 1998), 2016. [cited 2019 Aug 19]. Available at: http://www.gbe-bund.de/gbe10/abrechnung.prc_abr_test_logon?p_uid=gast&p_aid=14709305&p_knoten=VR&p_sprache=E&p_suchstring=varicella
- Federal Statistical Office: Diagnostic data of the prevention and rehabilitation facilities with more than 100 beds, 2017. [cited 2019 Aug 19]. Available at: http://www.gbe-bund.de/gbe10/abrechnung.prc_abr_test_logon?p_uid=gast&p_aid=14709305&p_knoten=VR&p_sprache=E&p_suchstring=varicella
- Federal Statistical Office: Vaccine coverage of children starting school, 2017. [cited 2019 Aug 19]. Available at: http://www.gbe-bund.de/gbe10/abrechnung.prc_abr_test_logon?p_uid=gast&p_aid=14709305&p_knoten=VR&p_sprache=E&p_suchstring=varicella
- Banz K, Wagenpfeil S, Neiss A, et al. The cost-effectiveness of routine childhood varicella vaccination in Germany. Vaccine. 2003 Mar 7;21(11–12):1256–1267.
- Beutels P, Clara R, Tormans G, et al. Costs and benefits of routine varicella vaccination in German children. J Infect Dis. 1996 Nov;174(Suppl 3):S335–41.
- Coudeville L, Brunot A, Giaquinto C, et al. Varicella vaccination in Italy: An economic evaluation of different scenarios. Pharmacoeconomics. 2004;22(13):839–855.
- Coudeville L, Brunot A, Szucs TD, et al. The economic value of childhood varicella vaccination in France and Germany. Value Health. 2005 May-Jun;8(3):209–222.
- Gabutti G, Azzari C. [Priorix Tetra: A new combined vaccine against measles, rubella, mumps and varicella]. Minerva Pediatr. 2008 Aug;60(4):429–441. Italian
- Gabutti G, Penna C, Rossi M, et al. The seroepidemiology of varicella in Italy. Epidemiol Infect. 2001 Jun;126(3):433–440.
- Guzzetta G, Poletti P, Merler S, et al. The epidemiology of herpes zoster after varicella immunization under different biological hypotheses: Perspectives from mathematical modeling. Am J Epidemiol. 2016 Apr 15;183(8):765–773.
- Hammerschmidt T, Bisanz H, Wutzler P. Universal mass vaccination against varicella in Germany using an MMRV combination vaccine with a two-dose schedule: An economic analysis. Vaccine. 2007 Oct 16;25(42):7307–7312.
- Knuf M, Neiss A, Wutzler P. [Impact of universal varicella vaccination in Germany: An epidemiological and economic analysis]. Klin Padiatr. 2006 Jul-Aug;218(4):203–212. German
- Nicolosi A, Sturkenboom M, Mannino S, et al. The incidence of varicella: Correction of a common error. Epidemiology. 2003 Jan;14(1):99–102.
- Poletti P, Melegaro A, Ajelli M, et al. Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries. PLoS One. 2013;8(4):e60732.
- Streng A, Liese JG. Decline of varicella vaccination in German surveillance regions after recommendation of separate first-dose vaccination for varicella and measles-mumps-rubella. Vaccine. 2014 Feb 12;32(8):897–900.
- Wagenpfeil S, Neiss A, Banz K, et al. Empirical data on the varicella situation in Germany for vaccination decisions. Clin Microbiol Infect. 2004 May;10(5):425–430.
- Weisser K, Meyer C, Petzold D, et al. [Adverse drug reactions following immunization in Germany pursuant to the German infection protection act and the german medicinal products act from January 1, 2004 to December 31, 2005]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007 Nov;50(11):1404–1417. German
- Wutzler P, Farber I, Wagenpfeil S, et al. Seroprevalence of varicella-zoster virus in the German population. Vaccine. 2001 Oct 12;20(1–2):121–124.
- Wutzler P, Neiss A, Banz K, et al. Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany. Med Microbiol Immunol. 2002 Oct;191(2):89–96.
- Ziebold C, von Kries R, Lang R, et al. Severe complications of varicella in previously healthy children in Germany: A 1-year survey. Pediatrics. 2001 Nov;108(5):E79.
- De Donno A, Kuhdari P, Guido M, et al. Has VZV epidemiology changed in Italy? Results of a seroprevalence study. Hum Vaccin Immunother. 2017 Feb;13(2):385–390.
- Melegaro A, Marziano V, Del Fava E, et al. The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: A modelling and cost-effectiveness study. BMC Med. 2018 Jul 17;16(1):117.
- Pezzotti P, Bellino S, Prestinaci F, et al. The impact of immunization programs on 10 vaccine preventable diseases in Italy: 1900–2015. Vaccine. 2018 Mar 7;36(11):1435–1443.
- Valente N, Cocchio S, Stefanati A, et al. Temporal trends in herpes zoster-related hospitalizations in Italy, 2001–2013: Differences between regions that have or have not implemented varicella vaccination. Aging Clin Exp Res. 2017 Aug;29(4):771–779.
- Alfonsi V, D’Ancona F, Giambi C, et al. Current immunization policies for pneumococcal, meningococcal C, varicella and rotavirus vaccinations in Italy. Health Policy. 2011 Dec;103(2–3):176–183.
- Betta M, Laurino M, Pugliese A, et al. Perspectives on optimal control of varicella and herpes zoster by mass routine varicella vaccination. Proc Biol Sci. 2016 Mar 16;283(1826):20160054.
- Bonanni P, Boccalini S, Bechini A, et al. Economic evaluation of varicella vaccination in Italian children and adolescents according to different intervention strategies: The burden of uncomplicated hospitalised cases. Vaccine. 2008 Oct 16;26(44):5619–5626.
- Gabutti G, Rota MC, Guido M, et al. The epidemiology of Varicella Zoster virus infection in Italy. BMC Public Health. 2008;8(1):372.
- Holl K, Sauboin C, Amodio E, et al. Coverage, efficacy or dosing interval: Which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? A model-based study for Italy. BMC Public Health. 2016 Oct 21;16(1):1103.
- Ciofi Degli Atti ML, Rota MC, Mandolini D, et al. Assessment of varicella underreporting in Italy. Epidemiol Infect. 2002 Jun;128(3):479–484.
- Ciofi Degli Atti ML, Salmaso S, Bella A, et al. Pediatric sentinel surveillance of vaccine-preventable diseases in Italy. Pediatr Infect Dis J. 2002 Aug;21(8):763–768.
- Fornaro P, Gandini F, Marin M, et al. Epidemiology and cost analysis of varicella in Italy: Results of a sentinel study in the pediatric practice. Italian sentinel group on pediatric infectious diseases. Pediatr Infect Dis J. 1999 May;18(5):414–419.
- Giaquinto C, Sturkenboom M, Mannino S, et al. [Epidemiology and outcomes of varicella in Italy: Results of a prospective study of children (0–14 years old) followed up by pediatricians (Pedianet study)]. Ann Ig. 2002 Jul-Aug;14(4Suppl 6):21–27. Italian
- Salmaso S, Mandolini D, Scalia Tomba G, et al. [Prevention of varicella in Italy: Vaccination strategies]. Ann Ig. 2002 Jul-Aug;14(4Suppl 6):35–44. Italian
- Salmaso S, Tomba GS, Mandolini D, et al. [Assessment of the potential impact in Italy of extensive varicella vaccination programs based on a mathematical model]. Epidemiol Prev. 2003 May-Jun;27(3):154–160. Italian
- Santuccio C, Trotta F, Felicetti P, et al.: Post-marketing surveillance on vaccines in Italy 2013, AIFA. 2013 [cited 2019 Nov 1]. Available at: https://www.aifa.gov.it/documents/20142/516919/Rapporto_vaccini_2013_acc_0.pdf/b3e3bd1e-020a-1118-bb48-d6723fd578d6.
- EUVAC.NET. Varicella surveillance report 2000–2007, [cited 2019 Aug 19]. Available at: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/varicella_report_2000_2007_euvacnet.pdf
- EUVAC.NET. Varicella surveillance report 2008–2009, [cited 2019 Aug 19]. Available at: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/varicella_report_2008_2009_euvacnet.pdf
- EUVAC.NET. Varicella surveillance report 2010, [cited 2019 Aug 19]. Available at: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/varicella_report_2010_euvacnet.pdf
- Sbarbati M, Di Pietro AC: Hospitalisations for varicella and measles in children younger than 2 years in 2006–2011 in Italy: A cross sectional study utilising national hospital discharge database. Presented at the ECCMID. 2014 [cited 2019 Nov 1]. #P1862, Available at https://www.escmid.org/escmid_publications/escmid_elibrary/.
- Signorelli C: Andamento delle coperture vaccinali in Italia. 2016 [cited 2019 Nov 1]. Available at http://www.igienistionline.it/docs/2016/37sigministero.pdf.
- Baldo V, Baldovin T, Russo F, et al. Varicella: Epidemiological aspects and vaccination coverage in the Veneto Region. BMC Infect Dis. 2009 Sep 8;9:150.
- Bechini A, Chellini M, Pellegrino E, et al. Impact of vaccination programs against measles, varicella and meningococcus C in Italy and in Tuscany and public health policies in the last decades. J Prev Med Hyg. 2018 Jun;59(2):E120–E127.
- Boccalini S, Bonanni P, Bechini A. Preparing to introduce the varicella vaccine into the Italian immunisation programme: Varicella-related hospitalisations in Tuscany, 2004–2012. Euro Surveill. 2016 Jun 16;21(24).
- Cuccia M, Addario PS, Cernigliaro A, et al. [Varicella vaccine in the Sicilian region: Impact on hospitalizations and notifications]. Medico e Bambino pagine elettroniche. 2010;13(4): Italian.
- Gabutti G, Rota MC, De Donno A, et al. [Sero-epidemiology of VZV infection in Italy: Impact evaluation of extensive vaccination]. Epidemiol Prev. 2014 Nov-Dec;38(6Suppl 2):57–61. Italian
- Gialloreti LE, Divizia M, Pica F, et al. Analysis of the cost-effectiveness of varicella vaccine programmes based on an observational survey in the Latium region of Italy. Herpes:J IHMF. 2005 Oct;12(2):33–37.
- Giammanco G, Ciriminna S, Barberi I, et al. Universal varicella vaccination in the Sicilian paediatric population: Rapid uptake of the vaccination programme and morbidity trends over five years. Euro Surveill. 2009 Sep 3;14(35):19321.
- Giaquinto C, Gabutti G, Baldo V, et al. Impact of a vaccination programme in children vaccinated with ProQuad, and ProQuad-specific effectiveness against varicella in the Veneto region of Italy. BMC Infect Dis. 2018 Mar 5;18(1):103.
- Marchetto S, de Benedictis FM, de Martino M, et al. Epidemiology of hospital admissions for chickenpox in children: An Italian multicentre study in the pre-vaccine era. Acta Paediatr. 2007 Oct;96(10):1490–1493.
- Tafuri S, Gallone MS, Cappelli MG, et al. A seroprevalence survey on varicella among adults in the vaccination era in Apulia (Italy). Vaccine. 2014 Nov 12;32(48):6544–6547.
- Tafuri S, Martinelli D, Prato R, et al. Vaccine effectiveness evaluation during a varicella outbreak among children of primary schools and day-care centers in a region which adopted UMV. Hum Vaccin Immunother. 2013 Jan;9(1):184–188.
- Azzari C, Massai C, Poggiolesi C, et al. Cost of varicella-related hospitalisations in an Italian paediatric hospital: Comparison with possible vaccination expenses. Curr Med Res Opin. 2007 Dec;23(12):2945–2954.
- Baldo V, Ferro A, Napoletano G, et al. Universal varicella vaccination in the Veneto Region, Italy: Launch of a programme targeting all children aged 14 months and susceptible adolescents. Euro Surveill. 2007 Nov 1;12(11):E071101.3.
- Bechini A, Boccalini S, Baldo V, et al. Impact of universal vaccination against varicella in Italy. Hum Vaccin Immunother. 2015;11(1): 63–71.
- Bonanni P, Ferro A, Guerra R, et al. Vaccine coverage in Italy and assessment of the 2012–2014 National Immunization Prevention Plan. Epidemiol Prev. 2015;Jul-Aug;39(4 Suppl 1):146–158.
- Bonsignori F, Chiappini E, Frenos S, et al. Hospitalization rates for complicated and uncomplicated chickenpox in a poorly vaccined pediatric population. Infection. 2007 Dec;35(6):444–450.
- Cocchio S, Zanoni G, Opri R, et al. A postmarket safety comparison of 2 vaccination strategies for measles, mumps, rubella and varicella in Italy. Hum Vaccin Immunother. 2016 Mar 3;12(3):651–654.
- Frenos S, Galli L, Chiappini E, et al. An increasing incidence of chickenpox central nervous system complications in children: What’s happening in Tuscany? J Clin Virol. 2007 Apr;38(4):358–361.
- Moretti F, Chellini E, Baretti S, et al. [Estimate of underreporting of infectious diseases through a sentinel network of pediatricians in the area of local health unit of Florence]. Epidemiol Prev. 2000 Sep-Oct;24(5):224–227. Italian
- Pieri L, Porchia BR, Pieralli F, et al. Assessment of the effectiveness of the universal varicella vaccination program in Toscana (Italy), in the period 2010–2013. Epidemiol Prev. 2015 Jul-Aug;39(4 Suppl 1):119–123.
- Pozza F, Piovesan C, Russo F, et al. Impact of universal vaccination on the epidemiology of varicella in Veneto, Italy. Vaccine. 2011 Nov 28;29(51):9480–9487.
- Tafuri S, Fortunato F, Cappelli MG, et al. Effectiveness of vaccination against varicella in children under 5 years in Puglia, Italy 2006–2012. Hum Vaccin Immunother. 2015;11(1):214–219.
- Trucchi C, Gabutti G, Rota MC, et al. Burden of varicella in Italy, 2001–2010: Analysis of data from multiple sources and assessment of universal vaccination impact in three pilot regions. J Med Microbiol. 2015 Nov;64(11):1387–1394.
- Zotti CM, Maggiorotto G, Migliardi A. [Costs of varicella]. Ann Ig. 2002 Jul-Aug;14(4Suppl 6):29–33. Italian
- Gatti MG, Grandori L, Poggioli P, et al. Monitoring of adverse events in vaccines given at age 0–17, reported in the Province of Modena from 2002 to 2005. Available at: https://www.epicentro.iss.it/vaccini/pdf/Reavac_2002-2005_MO.pdf cited 2019 Sept 03
- Servi Sociali Sanita: Official bulletin of the Lombardy region: Suppl. Straordinario al n. 4–24 gennaio 2006, 2006. [cited 2019 Sept 03]. Available at: https://www.epicentro.iss.it/vaccini/pdf/Normative/Lombardia_%20Dicembre%202012/DGR%20n%C2%B0%208-1587%20del%2022.12.2005.pdf
- Russo F, Piovesan C, Pozza F, et al.: Special objectives of infectious disease 2010, Region of Veneto, 2011. [cited 2019 Sept 03]. Available at: https://www.epicentro.iss.it/territorio/veneto/pdf/RappMI2010.pdf
- Various: Vaccinations in Piedmont, 2018. [cited 2019 Sept 03]. Available at: https://www.epicentro.iss.it/territorio/piemonte/documentazione
- Gatti MG, Pascucci MG, Carati D, et al. Surveillance of adverse events to vaccines given at age 0–17 years reported in Emilia-Romagna period 2006–2007, 2008. [cited 2019 Sept 03]. Available at: https://www.epicentro.iss.it/territorio/emilia-romagna/pdf/eventi_avversi_E-R_2006-07.pdf
- Russo F, Da Re F, Zanella F, et al.: Special objectives of infectious disease 2012–2013, Region of Veneto, 2013. [cited 2019 Sept 03]. Available at: https://www.epicentro.iss.it/territorio/veneto/pdf/REPORT%20MI6_def.pdf
- Gatti MG, Floramo M, Soncini F, et al. Surveillance of adverse events to vaccines reported in Emilia-Romagna in pediatric age (2006–2011) and adult (2010–2011), 2013. [cited 2019 Sept 03]. Available at: https://www.epicentro.iss.it/vaccini/pdf/Vaccini_reazioni_avverse_pediatrico_e_adulti_novembre2013.pdf
- Various: Infectious diseases: 2016 archives, 2016. [Cited 2019 Sept 03]. Available at: https://www.epicentro.iss.it/infettive/archivio2016
- Assessorato Dell’igiene E Sanita’ E Dell’assistenza Sociale Servizio Prevenzione: Regional plan for prevention 2010 – 2012: Regione Sardegna. [Cited 2019 Aug 19]. Available at: https://www.epicentro.iss.it/vaccini/pdf/Normative/Sardegna_Dicembre%202010/PRP%202010_12%20DGR%20n%C2%B0%2047-24%20del%2030.12.10/PRP%202010-12%20quadro-strategico.pdf
- Dipartimento di Prevenzione ASLdA-B: Bollettino Epidemiologico Anno 2011, Region Piedmont, 2011. [Cited 2019 Aug 19]. Available at: https://www.epicentro.iss.it/territorio/piemonte/pdf/Bollettino%20epidemiologico%202011.pdf
- Dipartimento di Prevenzione ASLdP: Bollettino Epidemiologico Anno 2005, Region Piedmont, 2005. [Cited 2019 Aug 19]. Available at: https://www.epicentro.iss.it/territorio/piemonte/pdf/Asl18_Bollettino2005.PDF
- Borello D: Bollettino Epidemiologico Anno 2014, Region Piedmont, ASL di Alba-Bra, 2015. [Cited 2019 Aug 19]. Available at: https://www.epicentro.iss.it/territorio/piemonte/pdf/Bollettino%20Epidemiologico%202014.pdf
- Marinaro L: Bollettino Epidemiologico Anno 2003, Region Piedmont, ASL di Alba-Bra, 2003. [Cited 2019 Aug 19]. Available at: https://www.epicentro.iss.it/territorio/piemonte/pdf/Bra2003%20.pdf
- Agnelli I: Bollettino Epidemiologico Anno 2006, Region Piedmont, ASL di Alba-Bra, 2006. [Cited 2019 Aug 19]. Available at: https://www.epicentro.iss.it/territorio/piemonte/pdf/epid_asl18_2006.pdf
- Epicentro.iss: Incidence per 100.000 children 0–14 years of age for vaccine-preventable diseases, by geographic region and data source, Italy, 2000. [Cited 2019 Aug 19]. Available at: http://www.epicentro.iss.it/ben/2001/maggio/tab2_eng.pdf
- Dipartimento di Prevenzione ASLdA-B: Bollettino Epidemiologico Anno 2012, Region Piedmont, ASL di Alba-Bra, 2012. [Cited 2019 Sept 03]. Available at: https://www.epicentro.iss.it/territorio/piemonte/pdf/Bollettino%20Epidemiologico%202012.pdf
- Dipartimento di Prevenzione ASLdA-B: Bollettino Epidemiologico Anno 2013, Region Piedmont, ASL di Alba-Bra, 2013. [Cited 2019 Sept 03]. Available at: https://www.epicentro.iss.it/territorio/piemonte/pdf/Bollettino%20Epidemiologico%20ASLCN2%20Anno%202013.pdf
- Marchione P, Menniti-Ippolito F, Felicetti P, et al. Rapporto vaccini 2017. 2017 [cited 2019 Nov 1]. Available at: http://www.agenziafarmaco.gov.it//sites/default/files/Rapp_Vaccini_2017.pdf.
- Tafuri S, Guerra R, Cappelli MG, et al. Determinants of varicella breakthrough: Results of a 2012 case-control study. Hum Vaccin Immunother. 2014;10(3):667–670.
- Ciofi Degli Atti ML, Rota MC, Mandolini D, et al. Assessment of varicella underreporting in Italy. Epidemiol Infect. 2002;128(3):479–484.
- Gazzetta ufficiale della regione Siciliana. Palermo - Venerdì 16 Agosto 2002 - n. 38. Vaccinazione anti-varicella nella Regione siciliana. [Cited 2019 Feb 13]. Available at: http://www.gurs.regione.sicilia.it/Gazzette/g02-38.HTM#24.
- Robert-Koch-Institut. Epidemiol Bull 2005; 13: S111–112. [Cited 2019 Feb 4]. Available at: https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2005/Ausgabenlinks/13_05.pdf?__blob=publicationFile
- Regione Toscana [Tuscany Region]. Aggiornamento direttive regionali in materia di vaccinazioni [Updating the regional guidelines on vaccinations]. Revoca delibere n. 1249 del 24/ 11/2003,n.379 del 7/3/2005 e n.1060 del 10/ 10/2000.Modifica delibera n. 1386 del 17/ 12/2001.Deliberazione Giunta Regionale del 27 dicembre 2007, n. 1020, Bollettino Ufficiale Della Regione Toscana, N. 2 del 9.1.2008. Italian. [Cited 2019 Feb 4]. Available at: http://www.fimptoscana.org/system/files/delibera%20calendario%20regionale%2027-12-2007_0.pdf
- Ministero della Salute. Vaccinazioni dell’età pediatrica e dell’adolescente - Coperture vaccinali. [Cited 2019 Feb 13]. Available at: http://www.salute.gov.it/portale/documentazione/p6_2_8_3_1.jsp?lingua=italiano&id=20
- Ministero della Salute. Piano nazionale prevenzione vaccinale 2017–2019. [Cited 2019 Apr 10]. Available at: https://www.gazzettaufficiale.it/eli/gu/2017/02/18/41/sg/pdf
- Ministero della Salute. Circolare recante prime indicazioni operative per l’attuazione del decreto-legge 7 giugno 2017, n.73, recante “Disposizioni urgenti in materia di prevenzione vaccinale”. 2017. [Cited 2019 Feb 13]. Available at: http://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2017&codLeg=60282&parte=1%20&serie=null
- Ministero della Salute. Piano nazionale prevenzione vaccinale 2005–2007. [Cited 2019 Apr 10]. Available at: http://www.salute.gov.it/imgs/C_17_pubblicazioni_543_allegato.pdf
- Empfehlungen der Ständigen Impfkommission am Robert-Koch-Institut (STIKO). Epidemiol bull 2009; 32: 319–338. [Cited 2019 Feb 4]. Available at: https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2009/Ausgaben/32_09.pdf%3F__blob%3DpublicationFile
- Wiese-Posselt M, Hellenbrand W. Changes to the varicella and pertussis immunisation schedule in Germany 2009: Background, rationale and implementation. Euro Surveill. 2010 Apr 22;15:16.
- Jacobsen SJ, Ackerson BK, Sy LS, et al. Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting. Vaccine. 2009 Jul 23;27(34):4656–4661.
- Klein NP, Fireman B, Yih WK, et al. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics. 2010 Jul;126(1):e1–8.
- Wutzler P, Casabona G, Cnops J, et al. Herpes zoster in the context of varicella vaccination - An equation with several variables. Vaccine. 2018 Nov 12;36(46):7072–7082.
- Brisson M, Edmunds WJ, Gay NJ. Varicella vaccination: Impact of vaccine efficacy on the epidemiology of VZV. J Med Virol. 2003;70(Suppl S1):S31–7.
- Leung J, Harpaz R, Molinari NA, et al. Herpes zoster incidence among insured persons in the United States, 1993–2006: Evaluation of impact of varicella vaccination. Clin Infect Dis. 2011 Feb 1;52(3):332–340.
- Harpaz R, van Hoek AJ. Point-counterpoint: The Hope-simpson hypothesis and its implications regarding an effect of routine varicella vaccination on herpes zoster incidence. J Infect Dis. 2018 Sep 22;218(suppl_2):S57–S62.
- Harpaz R. Do varicella vaccination programs change the epidemiology of herpes zoster? A comprehensive review, with focus on the United States. Expert Rev Vaccines. 2019 Aug;18(8):793–811.
- Forbes H, Douglas I, Finn A, et al. Risk of herpes zoster after exposure to varicella to explore the exogenous boosting hypothesis: Self controlled case series study using UK electronic healthcare data. BMJ. 2020 Jan 22:368:l6987. doi10.1136/bmj.l6987.
- Wolfson LJ, Daniels VJ, Altland A, et al. The impact of varicella vaccination on the incidence of varicella and herpes zoster in the United States: Updated evidence from observational databases, 1991–2016. Clin Infect Dis. 2020 Mar 3;70(6):995–1002.
- Weinmann S, Naleway AL, Koppolu P, et al. Incidence of Herpes Zoster Among Children: 2003–2014. Pediatrics. 2019 Jul;144(1):e20182917.
- Harpaz R, Leung JW. The epidemiology of herpes zoster in the United States during the era of varicella and herpes zoster vaccines: Changing patterns among children. Clin Infect Dis. 2019 Jul 2;69(2):345–347.
- Sauboin C, Holl K, Bonanni P, et al. The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: Modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting. BMC Infect Dis. 2019 Feb 6;19(1):126.
- Ogunjimi B, Smits E, Hens N, et al. Exploring the impact of exposure to primary varicella in children on varicella-zoster virus immunity of parents. Viral Immunol. 2011 Apr;24(2):151–157.
- Ogunjimi B, Van den Bergh J, Meysman P, et al. Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox. Sci Rep. 2017 Apr 24;7(1):1077.
- Gaillat J, Gajdos V, Launay O, et al. Does monastic life predispose to the risk of Saint Anthony’s fire (herpes zoster)? Clin Infect Dis. 2011 Sep;53(5):405–410.
- Robert-Koch-Institut. Epidemiol Bull 2018; 50: 541–570. [Cited 2019 Feb 4]. Available at: https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2018/Ausgaben/50_18.pdf?__blob=publicationFile
- Priorix Tetra. Summary of product characteristics. [Cited 2019 Aug 26]. Available at: https://farmaci.agenziafarmaco.gov.it/aifa/servlet/PdfDownloadServlet?pdfFileName=footer_000200_038200_RCP.pdf&retry=0&sys=m0b1l3
- ProQuad. Summary of product characteristics. [Cited 2019 Aug 26]. Available at: https://farmaci.agenziafarmaco.gov.it/aifa/servlet/PdfDownloadServlet?pdfFileName=footer_000737_036893_RCP.pdf&retry=0&sys=m0b1l3
- Empfehlungen der Ständigen Impfkommission am Robert-Koch-Institut (STIKO). Epidemiol Bull. 2005. 30:257–272. [Cited 2019 Feb 4]. Available at: https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2005/Ausgabenlinks/30_05.pdf?__blob=publicationFile.
- Finn A. The hope-simpson hypothesis, varicella vaccination and herpes zoster control. J Infect Dis. 2019;219(10):1681.